Yahoo: UC a top college for people with Down syndrome
The University of Cincinnati's Transition and Access Program gives people with intellectual disabilities a full four-year college experience
The Transition and Access Program (TAP) at the University of Cincinnati has received national attention for the opportunities it affords to students with Down syndrome and other intellectual disabilities.
"Thanks to full inclusion into mainstream schools, people with Down syndrome are learning right alongside their peers — and doing great," according to the Yahoo Lifestyle article, "20 Companies That Employ People With Down Syndrome."
TAP is one of the first programs in the country to offer students with intellectual disabilities the opportunity to have a four-year college experience. And unlike any other program of its kind, TAP students are regarded as students of the university and full members of the UC community.
"Students live in the residence halls, attend classes, engage in internships and participate in an active social life," according to the Yahoo article. "TAP’s mission is to enhance the quality of life of students through advocacy, access and research. TAP aims to provide a post-secondary experience for every person who desires it."
TAP exemplifies Inclusive Excellence, which drives the university's strategic direction, Next Lives Here.
The Advancement & Transition Services programs offered by UC's College of Education, Criminal Justice, and Human Services — including TAP — help young people and adults with a wide range of intellectual and developmental disabilities discover and fulfill their purpose.
Featured Image: TAP students look down from the patio at the UC TAP House. Photo/Joseph Fuqua II/UC Creative Services
Related Stories
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.
UC co-op offers a glimpse into the future
March 12, 2026
UC engineering student Savannah Dickens wore many hats at companies during her co-op rotations. She will graduate this spring and a has a job lined up with Davey Resource Group in Akron, Ohio.